Wave Life Sciences Files 8-K
Ticker: WVE · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
Topics: listing, corporate-disclosure
Related Tickers: WVE
TL;DR
WVE's 8-K filed Jan 13, 2025 confirms Nasdaq listing.
AI Summary
Wave Life Sciences Ltd. reported on January 13, 2025, that its ordinary shares are traded on The Nasdaq Global Market under the ticker symbol WVE. The company is incorporated in Singapore and its principal executive offices are located at 7 Straits View #12-00, Marina One East Tower, Singapore 018936. The filing is a current report (Form 8-K) filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing confirms the company's reporting status and stock exchange listing, providing essential information for investors and regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- January 13, 2025 (date) — Date of earliest event reported
- WVE (company) — Trading symbol
- The Nasdaq Global Market (company) — Stock exchange
- Singapore (location) — Place of incorporation and principal executive offices
FAQ
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to serve as a current report for Wave Life Sciences Ltd., indicating the date of the earliest event reported as January 13, 2025, and confirming its reporting obligations under the Securities Exchange Act of 1934.
On which stock exchange are Wave Life Sciences Ltd.'s ordinary shares traded?
Wave Life Sciences Ltd.'s ordinary shares are traded on The Nasdaq Global Market.
What is the trading symbol for Wave Life Sciences Ltd. on The Nasdaq Global Market?
The trading symbol for Wave Life Sciences Ltd. on The Nasdaq Global Market is WVE.
Where are the principal executive offices of Wave Life Sciences Ltd. located?
The principal executive offices of Wave Life Sciences Ltd. are located at 7 Straits View #12-00, Marina One East Tower, Singapore 018936.
In which jurisdiction is Wave Life Sciences Ltd. incorporated?
Wave Life Sciences Ltd. is incorporated in Singapore.
Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-01-13 14:00:20
Key Financial Figures
- $0 — of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d924989d8k.htm (8-K) — 25KB
- d924989dex991.htm (EX-99.1) — 35KB
- g924989ex99_1p10g1.jpg (GRAPHIC) — 216KB
- g924989ex99_1p11g1.jpg (GRAPHIC) — 259KB
- g924989ex99_1p12g1.jpg (GRAPHIC) — 258KB
- g924989ex99_1p13g1.jpg (GRAPHIC) — 198KB
- g924989ex99_1p14g1.jpg (GRAPHIC) — 252KB
- g924989ex99_1p15g1.jpg (GRAPHIC) — 241KB
- g924989ex99_1p16g1.jpg (GRAPHIC) — 165KB
- g924989ex99_1p17g1.jpg (GRAPHIC) — 227KB
- g924989ex99_1p18g1.jpg (GRAPHIC) — 270KB
- g924989ex99_1p19g1.jpg (GRAPHIC) — 288KB
- g924989ex99_1p1g1.jpg (GRAPHIC) — 374KB
- g924989ex99_1p20g1.jpg (GRAPHIC) — 211KB
- g924989ex99_1p21g1.jpg (GRAPHIC) — 271KB
- g924989ex99_1p22g1.jpg (GRAPHIC) — 256KB
- g924989ex99_1p23g1.jpg (GRAPHIC) — 169KB
- g924989ex99_1p24g1.jpg (GRAPHIC) — 317KB
- g924989ex99_1p25g1.jpg (GRAPHIC) — 287KB
- g924989ex99_1p26g1.jpg (GRAPHIC) — 230KB
- g924989ex99_1p27g1.jpg (GRAPHIC) — 202KB
- g924989ex99_1p28g1.jpg (GRAPHIC) — 233KB
- g924989ex99_1p29g1.jpg (GRAPHIC) — 250KB
- g924989ex99_1p2g1.jpg (GRAPHIC) — 363KB
- g924989ex99_1p30g1.jpg (GRAPHIC) — 214KB
- g924989ex99_1p31g1.jpg (GRAPHIC) — 175KB
- g924989ex99_1p3g1.jpg (GRAPHIC) — 326KB
- g924989ex99_1p4g1.jpg (GRAPHIC) — 278KB
- g924989ex99_1p5g1.jpg (GRAPHIC) — 214KB
- g924989ex99_1p6g1.jpg (GRAPHIC) — 284KB
- g924989ex99_1p7g1.jpg (GRAPHIC) — 247KB
- g924989ex99_1p8g1.jpg (GRAPHIC) — 238KB
- g924989ex99_1p9g1.jpg (GRAPHIC) — 201KB
- 0001193125-25-005233.txt ( ) — 10823KB
- wve-20250113.xsd (EX-101.SCH) — 3KB
- wve-20250113_lab.xml (EX-101.LAB) — 18KB
- wve-20250113_pre.xml (EX-101.PRE) — 11KB
- d924989d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Corporate Presentation of Wave Life Sciences Ltd. dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Kyle Moran Kyle Moran Chief Financial Officer Date: January 13, 2025